A Phase II Study of the Combination Chemotherapy Consisted of Rituximab and THP-COP Regimen as First-Line Treatment for Patients with Diffuse Large B-Cell Lymphoma.

被引：0
|
作者：
Tsurumi, Hisashi [1 ]
Goto, Naoe [2 ]
Hara, Takeshi [1 ]
Kasahara, Senji [1 ]
Kanemura, Nobuhiro [1 ]
Kitagawa, Junichi [1 ]
Yoshikawa, Takeshi [3 ]
Yamada, Toshiki [1 ]
Sawada, Michio [1 ]
Takahashi, Takeshi [3 ]
Takami, Tsuyoshi [2 ]
Moriwaki, Hisataka [1 ]
机构：
[1] Gifu Univ, Grad Sch Med, Dept Internal Med 1, Gifu, Japan
[2] Gifu Univ, Grad Sch Med, Dept Immunopathol, Gifu, Japan
[3] Gifu Municipal Hosp, Div Hematol, Gifu, Japan
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1231 / 1231
页数：1
相关论文
共 50 条
  • [41] Efficacy of RCDOP regimen in the treatment of patients with diffuse large B-cell lymphoma
    曹怡文
    China Medical Abstracts(Internal Medicine), 2018, 35 (03) : 187 - 187
  • [42] Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi
    Merli, Francesco
    Cavallo, Federica
    Salvi, Flavia
    Tucci, Alessandra
    Musuraca, Gerardo
    Nassi, Luca
    Merli, Michele
    Tani, Monica
    Gini, Guido
    Ferrari, Angela
    Molinari, Anna Lia
    Liberati, Anna Marina
    Conconi, Annarita
    Matteucci, Paola
    Bari, Alessia
    Scalone, Renato
    Ferrero, Simone
    Zanni, Manuela
    Mammi, Caterina
    Luminari, Stefano
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (01) : 37 - 40
  • [43] Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory Diffuse Large B-cell Lymphoma. A phase II trial by the Hellenic Cooperative Oncology Group (HECOG).
    Papageorgiou, E
    Tsirigotis, P
    Dimopoulos, M
    Pavlidis, N
    Foutzilas, G
    Papageorgiou, S
    Economopoulos, T
    ANNALS OF ONCOLOGY, 2005, 16 : 220 - 220
  • [44] R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma
    Al-Sarayfi, Diana
    Meeuwes, Frederik O.
    Durmaz, Mujde
    Issa, Djamila E.
    Brouwer, Rolf E.
    Beeker, Aart
    van Rhenen, Anna
    Mutsaers, Pim G. N. J.
    Bohmer, Lara H.
    van der Poel, Marjolein W. M.
    te Boome, Liane
    van Meerten, Tom
    Chamuleau, Martine E. D.
    Zijlstra, Josee M.
    Brink, Mirian
    Nijland, Marcel
    BLOOD CANCER JOURNAL, 2022, 12 (09)
  • [45] R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma
    Diana Al-Sarayfi
    Frederik O. Meeuwes
    Müjde Durmaz
    Djamila E. Issa
    Rolf E. Brouwer
    Aart Beeker
    Anna van Rhenen
    Pim G. N. J. Mutsaers
    Lara H. Böhmer
    Marjolein W. M. van der Poel
    Liane te Boome
    Tom van Meerten
    Martine E. D. Chamuleau
    Josée M. Zijlstra
    Mirian Brink
    Marcel Nijland
    Blood Cancer Journal, 12
  • [46] Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Ohmachi, Ken
    Niitsu, Nozomi
    Uchida, Toshiki
    Kim, Seok Jin
    Ando, Kiyoshi
    Takahashi, Naoki
    Takahashi, Naoto
    Uike, Naokuni
    Eom, Hyeon Seok
    Chae, Yee Soo
    Terauchi, Takashi
    Tateishi, Ukihide
    Tatsumi, Mitsuaki
    Kim, Won Seog
    Tobinai, Kensei
    Suh, Cheolwon
    Ogura, Michinori
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (17) : 2103 - +
  • [47] A MULTICENTER PHASE II STUDY OF BENDAMUSTINE WITH RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
    Kim, W. S.
    Ando, K.
    Niitsu, N.
    Ogura, M.
    Takahashi, N.
    Uike, N.
    Eom, H. Seok
    Chae, Y. S.
    Tobinai, K.
    Terauchi, T.
    Tateishi, U.
    Tatsumi, M.
    Suh, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 94 - 94
  • [48] Smart start: Final results of rituximab, lenalidomide, and ibrutinib lead in prior to combination with chemotherapy for patients with newly diagnosed diffuse large B-cell lymphoma.
    Westin, Jason
    Nastoupil, Loretta J.
    Fayad, Luis
    Hagemeister, Fredrick B.
    Oki, Yasuhiro
    Turturro, Francesco
    Ahmed, Sairah
    Rodriguez, Maria Alma
    Lee, Hun Ju
    Steiner, Raphael
    Nair, Ranjit
    Parmar, Simrit
    Young, Ken H.
    McDonnell, Timothy
    Chuang, Hubert
    Green, Michael Richard
    Neelapu, Sattva Swarup
    Davis, Richard Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] Novel combination of gallium nitrate, rituximab and dexamethasone for the treatment of relapsed or refractory diffuse large B-cell lymphoma, mantle cell lymphoma or transformed follicular lymphoma.
    Smith, SE
    Stiff, PJ
    Rodriguez, T
    Toor, A
    Klein, J
    BLOOD, 2005, 106 (11) : 269B - 269B
  • [50] A phase II randomized study of lenalidomide or lenalidomide and rituximab as maintenance therapy following standard chemotherapy for patients with high/high-intermediate risk diffuse large B-cell lymphoma.
    Reddy, N. M.
    Simmons, R.
    Caldwell, M.
    Jagasia, M. H.
    Morgan, D. S.
    Park, S. I.
    Greer, J. P.
    Richards, K. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345